Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Rasi At The EMA: Redefining Benefit/Risk As Staggered Approvals Rise

Executive Summary

The Executive Director of the European Medicines Agency Guido Rasi’s dual goals of increasing safety and overall accountability undoubtedly will benefit patients and industry alike, but a grueling task lies ahead.

You may also be interested in...



InterMune, AbbVie Data Case Could Add Fuel To Wider European Disclosure Debates

In an interim judgment, the General Court of the European Union has stopped Europe’s top drug regulator from releasing trial data on Esbriet and Humira until it makes a final decision on access to such documents.

Europe Transparency Initiatives May Aid Progress Toward Adaptive Licensing Systems

Industry and regulators are showing more interest in implementing adaptive licensing in Europe. Both sides agree that increased trust and transparency could be stepping stones towards this goal.

EU Health Commissioner Candidate Remains Question Mark For Pharma

The European Parliament has voted in favor of Maltese Foreign Minister Tonio Borg’s candidacy for the vacant EU health commissioner post despite his lack of health policy experience.

Related Content

Topics

Related Companies

Latest News
UsernamePublicRestriction

Register

PS054481

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel